StockData
Moleculin Biotech, Inc. logo

Moleculin Biotech, Inc. (MBRX) stock

MBRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$7.87−0.19 (-2.36%)

Close on Nov 13, 2026Market cap $8.23MP/E –Yield –

Moleculin Biotech cash

Cash and short-term investments held at the end of each period.

Moleculin Biotech's cash was $7.29M at Sep 30, 2026. For fiscal 2025 it was $8.88M, up 107.5% from the year before. Over ten years it grew 77.9% a year on average. The highest annual figure on record is $70.90M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$8.88M+107.5%
FY2024Dec 31, 2024$4.28M-81.8%
FY2023Dec 31, 2023$23.55M-45.4%
FY2022Dec 31, 2022$43.15M-39.1%
FY2021Dec 31, 2021$70.90M+367.3%
FY2020Dec 31, 2020$15.17M+41.3%
FY2019Dec 31, 2019$10.74M+50.5%
FY2018Dec 31, 2018$7.13M-7.5%
FY2017Dec 31, 2017$7.71M+54.1%
FY2016Dec 31, 2016$5.01M+17782.1%
FY2015Dec 31, 2015$28.00K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$7.29M+8.7%
Q2 FY2026Jun 30, 2026$7.26M-3.9%
Q1 FY2026Mar 31, 2026$10.32M+33.7%
Q4 FY2025Dec 31, 2025$8.88M+107.5%
Q3 FY2025Sep 30, 2025$6.70M-28.7%
Q2 FY2025Jun 30, 2025$7.56M-30.3%
Q1 FY2025Mar 31, 2025$7.72M-54.1%
Q4 FY2024Dec 31, 2024$4.28M-81.8%
Q3 FY2024Sep 30, 2024$9.41M-61.7%
Q2 FY2024Jun 30, 2024$10.85M-66.3%
Q1 FY2024Mar 31, 2024$16.82M-54.9%
Q4 FY2023Dec 31, 2023$23.55M-45.4%
Q3 FY2023Sep 30, 2023$24.58M-51.2%
Q2 FY2023Jun 30, 2023$32.17M-44.5%
Q1 FY2023Mar 31, 2023$37.27M-43.6%
Q4 FY2022Dec 31, 2022$43.15M-39.1%
Q3 FY2022Sep 30, 2022$50.39M-33.0%
Q2 FY2022Jun 30, 2022$58.00M-27.1%
Q1 FY2022Mar 31, 2022$66.10M-23.4%
Q4 FY2021Dec 31, 2021$70.90M+367.3%
Q3 FY2021Sep 30, 2021$75.18M+487.6%
Q2 FY2021Jun 30, 2021$79.51M+375.1%
Q1 FY2021Mar 31, 2021$86.29M+640.8%
Q4 FY2020Dec 31, 2020$15.17M+41.3%
Q3 FY2020Sep 30, 2020$12.80M-17.0%
Q2 FY2020Jun 30, 2020$16.73M-10.5%
Q1 FY2020Mar 31, 2020$11.65M+32.6%
Q4 FY2019Dec 31, 2019$10.74M+50.5%
Q3 FY2019Sep 30, 2019$15.41M+79.2%
Q2 FY2019Jun 30, 2019$18.70M+59.5%
Q1 FY2019Mar 31, 2019$8.78M-33.0%
Q4 FY2018Dec 31, 2018$7.13M-7.5%
Q3 FY2018Sep 30, 2018$8.60M-1.6%
Q2 FY2018Jun 30, 2018$11.72M+26.4%
Q1 FY2018Mar 31, 2018$13.11M+161.9%
Q4 FY2017Dec 31, 2017$7.71M+24.7%
Q3 FY2017Sep 30, 2017$8.74M–
Q2 FY2017Jun 30, 2017$9.27M–
Q4 FY2016Dec 31, 2016$5.01M–
Q3 FY2016Sep 30, 2016$6.18M–

More Moleculin Biotech figures

See a number that looks wrong?